Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.

Kathleen N Potter, C Ian Mockridge, Louise Neville, Isla Wheatley, Michael Schenk, Jennifer Orchard, Andrew S Duncombe, Graham Packham, Freda K Stevenson

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1672-9

PMID: 16551848

Abstract

PURPOSE

To determine the origin and relationship of the rare IgG+ variant of chronic lymphocytic leukemia (CLL) to the two common IgM+IgD+ subsets that are distinguished by expression of unmutated or mutated V(H) genes, with the former having a worse prognosis.

EXPERIMENTAL DESIGN

IgG+ CLL cells were characterized using phenotypic, functional, and immunogenetic analyses.

RESULTS

IgG+ CLL was phenotypically similar to mutated IgM+IgD+ CLL (M-CLL) and variably expressed CD38 (4 of 14). ZAP-70, a tyrosine kinase preferentially expressed in unmutated CLL, was found in only 2 of 14 cases. The ability to signal via surface IgM (sIgM) varies between the main subsets of CLL and is associated with expression of ZAP-70. In IgG(+) CLL, 9 of 14 responded to engagement of sIgG with no apparent requirement for expression of CD38 or ZAP-70. However, signal capacity correlated with intensity of sIgG expression. Most switched immunoglobulin variable region genes were somatically mutated without intraclonal variation, and no case expressed activation-induced cytidine deaminase. Derivation from a postgerminal center B cell is, therefore, likely, and a relationship with M-CLL is suggested. This is supported by a shared biased usage of the V4-34 gene. Similar bias in normal B cells developed with age, providing an expanded population for transforming events. However, conserved sequences detected in the CDR3 of V4-34-encoded gamma chains were not found M-CLL, indicating no direct path of isotype switch from M-CLL.

CONCLUSION

IgG+ CLL is likely to arise from an age-related expanded pool of B cells, on a path parallel to M-CLL, and perhaps with a similar clinical course.

Address: Molecular Immunology Group, Tenovus Research Laboratory, Cancer Sciences Division, Southampton General Hospital, Southampton, UK. [email protected]

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.